Translation. Region: Russian Federation –
Source: Moscow Government – Moscow Government –
An important disclaimer is at the bottom of this article.
By 2025, the capital's enterprises increased the production of modern drugs for the treatment of the cardiovascular system by almost 80 percent. This was reported on his channel in MAX messenger Sergei Sobyanin reported.
"Moscow is one of the country's main centers of pharmaceutical production. We are among the leaders in the development and implementation of high-tech, full-cycle technologies. Today, Moscow enterprises create vital and essential medications. These include affordable drugs for the prevention of heart attacks and strokes, for the prevention of blood clots, and for the treatment of high blood pressure. The finished products are supplied throughout the country and beyond," the Moscow Mayor wrote.
Source: Sergei Sobyanin's channel inMAX messenger
For example, one of the capital's factories, which primarily produces original medications for the treatment of cardiovascular diseases, produced four million more packages in 2025. Of these, over 550,000 were exported.
To support this important industry, the city has created a whole range of measures, from tax breaks toinfrastructure solutionsOne of the largest companies operates in the Technopolis Moscow special economic zone. pharmaceutical clusters countries.
This work contributes to the development of national projects "A long and active life" AndHealth TechnologiesMore information about Russia's national projects and the capital's contribution can be found atspecial page.
Subscribe to Sergei Sobyanin's official channels on messengers MAX AndTelegram.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.